Ticker
NPCECompany Name
NEUROPACE INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Total Assets | Net Income Common Stock | Return on Assets |
---|---|---|---|
6/30/2025 | $ 106.11M | $ -25.94M | -24.45% |
3/31/2025 | $ 110.2M | $ -24.8M | -22.51% |
12/31/2024 | $ 94.65M | $ -27.14M | -28.68% |
9/30/2024 | $ 96.3M | $ -28.09M | -29.17% |
6/30/2024 | $ 94.39M | $ -29.9M | -31.67% |
3/31/2024 | $ 98.85M | $ -31.51M | -31.87% |
12/31/2023 | $ 107.65M | $ -32.96M | -30.61% |
9/30/2023 | $ 99.3M | $ -37.9M | -38.17% |
6/30/2023 | $ 102.23M | $ -42.43M | -41.5% |
3/31/2023 | $ 106.27M | $ -46M | -43.28% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Assets
(=) ROA
ROA for NEUROPACE INC is calculated as follows: Net Inc. Cmn. [ $ -24.28M ] / Assets [ $ 55.95M ]
(=) ROA [ -43.39% ]
Minimum
Dec 31, 2020
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 3.45K |
---|---|
min | -33.42% |
max | 33.98% |
average | 0.1% |
median | 1.53% |
std | 10.63% |